89 related articles for article (PubMed ID: 12649539)
1. Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats.
Valdivielso JM; Montero A; Badr KF; Munger KA
J Nephrol; 2003; 16(1):85-94. PubMed ID: 12649539
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 5-LO activating protein (FLAP) activity decreases proteinuria in streptozotocin (STZ)-induced diabetic rats.
Valdivielso JM; Montero A; Munger KA; Badr KF
Adv Exp Med Biol; 2002; 507():79-83. PubMed ID: 12664568
[No Abstract] [Full Text] [Related]
3. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
4. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis.
Montero A; Uda S; Kelavkar U; Yoshimura A; Badr KF; Munger KA
J Nephrol; 2003; 16(5):682-90. PubMed ID: 14733414
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Titos E; Clària J; Planagumà A; López-Parra M; González-Périz A; Gaya J; Miquel R; Arroyo V; Rodés J
J Leukoc Biol; 2005 Oct; 78(4):871-8. PubMed ID: 16033810
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
7. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
Persson P; Fasching A; Teerlink T; Hansell P; Palm F
Hypertension; 2014 Aug; 64(2):323-9. PubMed ID: 24866144
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.
Stridh S; Palm F; Takahashi T; Ikegami-Kawai M; Hansell P
Ups J Med Sci; 2015; 120(4):233-40. PubMed ID: 26175092
[TBL] [Abstract][Full Text] [Related]
9. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy.
Kang SW; Adler SG; Nast CC; LaPage J; Gu JL; Nadler JL; Natarajan R
Kidney Int; 2001 Apr; 59(4):1354-62. PubMed ID: 11260396
[TBL] [Abstract][Full Text] [Related]
10. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
[TBL] [Abstract][Full Text] [Related]
11. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403
[TBL] [Abstract][Full Text] [Related]
12. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis.
Katoh T; Lianos EA; Fukunaga M; Takahashi K; Badr KF
J Clin Invest; 1993 Apr; 91(4):1507-15. PubMed ID: 8386188
[TBL] [Abstract][Full Text] [Related]
14. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2004 Feb; 19(2):342-7. PubMed ID: 14736957
[TBL] [Abstract][Full Text] [Related]
16. Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis.
Rifai A; Sakai H; Yagame M
Kidney Int Suppl; 1993 Jan; 39():S95-9. PubMed ID: 8468935
[TBL] [Abstract][Full Text] [Related]
17. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.
Pace S; Pergola C; Dehm F; Rossi A; Gerstmeier J; Troisi F; Pein H; Schaible AM; Weinigel C; Rummler S; Northoff H; Laufer S; Maier TJ; Rådmark O; Samuelsson B; Koeberle A; Sautebin L; Werz O
J Clin Invest; 2017 Aug; 127(8):3167-3176. PubMed ID: 28737505
[TBL] [Abstract][Full Text] [Related]
18. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
[TBL] [Abstract][Full Text] [Related]
19. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
20. MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
Guasch A; Zayas CF; Badr KF
Kidney Int; 1999 Jul; 56(1):261-7. PubMed ID: 10411701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
